Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
bullish
Mayne Pharma
Watchlist
Mayne Well Positioned to Weather the Storm; Maintaining FVE and Very High Uncertainty
Equity Bottom-Up
120 Views
02 Jan 2018 03:51
We maintain our AUD 1.25 fair value estimate for no-moat Mayne Pharma given the recent update by management on the US generic industry trading...
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 57-minute read)
Related Insights
More »
Mayne Pharma (MYX AU): Entering Uncharted Territory as the Scheme Vote Passes
Mayne Pharma (MYX AU): The Vote Gets Up. Now What?
Mayne Pharma: No Precedence for a Deal Termination
Merger Arb Mondays (16 June) - Mayne, Pointsbet, Fengxiang, HKBN, Seven & I, Shibaura, Smartpay
Merger Arb Mondays (09 June) - Mayne, Tam Jai, OneConnect, Toyota Industries, Makino, Fuji Corp
Trending Collections
More »
Equity Bottom-Up
Index Rebalance
Event-Driven
Sell / Short Ideas
Asia Event-Driven
Japan
South Korea
India
Unpaywalled Insights
Philippines
Trending Insights
More »
Dian Swastatika Sentosa (DSSA IJ): Surprise, Surprise!
Korea Local Banks: New Dividend Tax Effectively Locks in a De Facto Minimum Yield Play
Intel. Crisis Mode All Over Again
Axalta Coating Systems Taps China & Latin America: Can They Build Volumes & Enable Global Mobility Expansion?
Q2 Holdings: Innovation Studio Adoption As A Significant Contributor To Growth!
Top Unpaywalled Insights
More »
[IO Technicals 2025/32] Bullish Momentum Builds
Grab Holdings (GRAB US) - Harvesting Sequentially
Micro-Mechanics (Holdings) Limited - Next Generation Supplier of the Semicon Industry
Bond Market Monitor: Thai Corporations UnSmiled
Rising Ringgit, Eroding Fundamentals
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
Mayne Well Positioned to Weather the Storm; Maintaining FVE and Very High Uncertainty
02 Jan 2018
Opportunity Knocks as Mayne Pharma Makes A Transformational Acquisition
29 Jun 2016
Mayne Pharma Focuses on Building Brand and Maintaining Momentum for Doryx
07 Sep 2015
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.55.4
x